These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27568311)

  • 1. Trends in metformin utilisation and dose appropriateness in Australia.
    Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1489-1496. PubMed ID: 27568311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, implementation and outcome analysis of semi-automated alerts for metformin dose adjustment in hospitalized patients with renal impairment.
    Niedrig D; Krattinger R; Jödicke A; Gött C; Bucklar G; Russmann S
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1204-1209. PubMed ID: 27418265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
    Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO
    Clin Pharmacokinet; 2013 May; 52(5):373-84. PubMed ID: 23475568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of oral antidiabetic agents in primary care.
    Weekes AJ; Thomas MC
    Aust Fam Physician; 2007 Jun; 36(6):477-80. PubMed ID: 17565410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In brief: New recommendations for use of metformin in renal impairment.
    Med Lett Drugs Ther; 2016 Apr; 58(1493):51. PubMed ID: 27101208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metformin, renal function and lactate: the MetClear Study].
    Mitrov-Winkelmolen L; Oude Engberink RD; Roelofs R; Ponjee GA; Vleming LJ; Wilms EB; Geelhoed-Duijvestijn NH
    Ned Tijdschr Geneeskd; 2014; 158(5):A6266. PubMed ID: 24472334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining metformin prescribing in New Zealand.
    Jayathissa S; Dixon P; Bruce R; Reith D
    N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients.
    Becquemont L; Bauduceau B; Benattar-Zibi L; Al-Salameh A; Berrut G; Bertin P; Bucher S; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Pasquier F; Pinget M; Ourabah R; Piedvache C
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):468-73. PubMed ID: 26573791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs.
    Gadzhanova S; Roughead EE; Loukas K; Vajda J
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):359-65. PubMed ID: 21442685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of metformin according to estimated glomerular filtration rate: the threshold and the equation are important.
    Rigalleau V; Lasseur C; Beauvieux MC; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
    Diabet Med; 2007 Dec; 24(12):1498-9. PubMed ID: 18042087
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of dosage adjustment in patients with renal impairment.
    Pillans PI; Landsberg PG; Fleming AM; Fanning M; Sturtevant JM
    Intern Med J; 2003; 33(1-2):10-3. PubMed ID: 12534872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
    Huang W; Castelino RL; Peterson GM
    Intern Med J; 2014 Mar; 44(3):266-72. PubMed ID: 24405767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency.
    Kalender-Rich JL; Mahnken JD; Wetmore JB; Rigler SK
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):320-7. PubMed ID: 21920825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.
    Warren RE; Strachan MW; Wild S; McKnight JA
    Diabet Med; 2007 May; 24(5):494-7. PubMed ID: 17367305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.
    Shaw JS; Wilmot RL; Kilpatrick ES
    Diabet Med; 2007 Oct; 24(10):1160-3. PubMed ID: 17672860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations.
    Frid A; Sterner GN; Löndahl M; Wiklander C; Cato A; Vinge E; Andersson A
    Diabetes Care; 2010 Jun; 33(6):1291-3. PubMed ID: 20215446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.